Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Quidel to Present Virtually at Raymond James Human Health Innovation Conference 2021
Quidel to Present Virtually at Raymond James Human Health Innovation Conference 2021


Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it will present at

League and Humana Partner to Digitally Transform Healthcare Experience for Millions of Members: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24514/Humana_logo.png
League and Humana Partner to Digitally Transform Healthcare Experience for Millions of Members


League, a technology-focused health company powering digital transformation in healthcare, and Humana Inc. (NYSE: HUM), a leading health and well-being company, today announced an agreement to

CenterWell Senior Primary Care to Open Six Senior-Focused Care Centers in Atlanta: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24514/Humana_logo.png
CenterWell Senior Primary Care to Open Six Senior-Focused Care Centers in Atlanta


CenterWell Senior Primary Care will open six new senior-focused primary care centers in metro Atlanta through 2022, marking the company’s debut in the Atlanta market, giving local seniors access to

Humana Names Carolyn Tandy Chief Inclusion and Diversity Officer
Humana Names Carolyn Tandy Chief Inclusion and Diversity Officer


Leading health and well-being company Humana Inc. (NYSE: HUM) has named Carolyn Tandy to the position of Senior Vice President and Chief Inclusion and Diversity Officer. Tandy will be responsible

Waters Sets New Standard in High Resolution Mass Spectrometry with SELECT SERIES Multi Reflecting Time-of-Flight Platform
Waters Sets New Standard in High Resolution Mass Spectrometry with SELECT SERIES Multi Reflecting Time-of-Flight Platform


Waters Corporation (NYSE:WAT) today introduced the Waters™ SELECT SERIES™ MRT, a high-resolution mass spectrometer that combines Multi Reflecting Time-of-Flight (MRT) technology with both enhanced

Dexcom richtet den Blick auf die Zukunft der kontinuierlichen Blutzuckermessung: https://mms.businesswire.com/media/20191106005764/en/685171/5/Dexcom_Registered_no_bug.jpg
Dexcom richtet den Blick auf die Zukunft der kontinuierlichen Blutzuckermessung


DexCom, Inc. (Nasdaq: DXCM), der Weltmarktführer im Bereich der kontinuierlichen Blutzuckermessung in Echtzeit für Menschen mit Diabetes, hat heute während der 14. Internationalen Konferenz über

Cell-Free DNA Guided Targeted Therapy Leads to Better Survival in Advanced Non-Small Cell Lung Cancerhttps://www.cyansecurity.com/:
Cell-Free DNA Guided Targeted Therapy Leads to Better Survival in Advanced Non-Small Cell Lung Cancer


Agilent Technologies Inc. (NYSE: A) today announced a presentation by Memorial Sloan Kettering Cancer Center (MSK) at the upcoming annual meeting of the American Society of Clinical Oncology (ASCO)

Dexcom Looks to the Future of Continuous Glucose Monitoring: https://mms.businesswire.com/media/20191106005764/en/685171/5/Dexcom_Registered_no_bug.jpg
Dexcom Looks to the Future of Continuous Glucose Monitoring


DexCom, Inc. (Nasdaq: DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today the publication and presentation of two new studies during the 14

PQA Presents CarePlus Health Plans with its Excellence in Quality Award: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24514/Humana_logo.png
PQA Presents CarePlus Health Plans with its Excellence in Quality Award


CarePlus Health Plans, Inc., Florida’s largest* 5 out of 5-star Medicare Advantage plan, has been recognized by the Pharmacy Quality Alliance (PQA) with its Excellence in Quality award for

Agilent Announces New SureSelect Human All Exon V8:
Agilent Announces New SureSelect Human All Exon V8


Agilent Technologies Inc. (NYSE: A) today announced the release of SureSelect Human All Exon V8 – a new exome design that provides comprehensive content and up-to-date coverage of protein coding

CenterWell Senior Primary Care Extends its Value-Based Care to People with Original Medicare: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24514/Humana_logo.png
CenterWell Senior Primary Care Extends its Value-Based Care to People with Original Medicare


CenterWell Senior Primary Care, a fast-growing provider of whole-person, senior-focused healthcare, is participating in a new federal population health program that will allow CenterWell to extend

Hanger to Present at the Jefferies Virtual Healthcare Conference
Hanger to Present at the Jefferies Virtual Healthcare Conference


Hanger, Inc. (NYSE: HNGR), a leading provider of orthotic and prosthetic patient care services and solutions, announced today that members of its management team will participate in presentations

Agilent Presents Thought Leader Award to Professor Chris Elliott
Agilent Presents Thought Leader Award to Professor Chris Elliott


Agilent Technologies Inc. (NYSE: A) today announced that Chris Elliott has received an Agilent Thought Leader Award. Dr. Elliott is Professor of Food Safety in the School of Biological Sciences and

Illumina Supports Nationwide Program across Belgium to Assess Whole Genome Sequencing for Developmental Disorders Diagnosis
Illumina Supports Nationwide Program across Belgium to Assess Whole Genome Sequencing for Developmental Disorders Diagnosis


Today, Illumina, Inc. (NASDAQ:ILMN) announced an agreement with the Belgian Genetic Centers to evaluate whole-genome sequencing (WGS) for the diagnosis of patients with intellectual disabilities

Illumina and Next Generation Genomic Partner to Launch VeriSeq™ NIPT Solution in Thailand
Illumina and Next Generation Genomic Partner to Launch VeriSeq™ NIPT Solution in Thailand


Illumina, Inc., the global leader in DNA sequencing and array-based technologies and Next Generation Genomic Co., Ltd. (NGG Thailand), the Association of Southeast Asian Nations (ASEAN) leaders in

Illumina To Webcast Upcoming Investor Conference
Illumina To Webcast Upcoming Investor Conference


Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at the following investor conference:




  • Goldman Sachs 42nd Annual Global Healthcare Conference on June 10, 2021

Humana Ranks #1 in J.D. Power Commercial Member Health Plan Study for Second Consecutive Year in Florida and Texas: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24514/Humana_logo.png
Humana Ranks #1 in J.D. Power Commercial Member Health Plan Study for Second Consecutive Year in Florida and Texas


Leading health and well-being company Humana Inc. (NYSE: HUM) announced today that for the second consecutive year, it is ranked #1 in Florida and Texas in the J.D. Power ranking of Commercial

Dexcom Announces Upcoming Conference Presentation: https://mms.businesswire.com/media/20191106005764/en/685171/5/Dexcom_Registered_no_bug.jpg
Dexcom Announces Upcoming Conference Presentation


DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on Dexcom at the following upcoming investor conference:




  • Jereme Sylvain, Executive Vice President and Chief

Simulations Plus to Participate in 18th Annual Craig-Hallum Institutional Investor Conference: https://mms.businesswire.com/media/20200318005128/en/780378/5/BusinessWireLogo.jpg
Simulations Plus to Participate in 18th Annual Craig-Hallum Institutional Investor Conference


Simulations Plus, Inc. (Nasdaq: SLP), a premier provider of simulation and modeling software and consulting services for pharmaceutical discovery and development, today announced that chief

Lantheus Receives U.S. FDA Approval of PYLARIFY® (piflufolastat F 18) Injection, the First and Only Commercially Available PSMA PET Imaging Agent for Prostate Cancer
Lantheus Receives U.S. FDA Approval of PYLARIFY® (piflufolastat F 18) Injection, the First and Only Commercially Available PSMA PET Imaging Agent for Prostate Cancer


Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), an established leader and fully integrated provider of innovative imaging diagnostics, targeted therapeutics and artificial intelligence

NanoString to Webcast Presentation from the Jefferies Virtual Healthcare Conference: https://mms.businesswire.com/media/20191104005218/en/753909/5/NSTG-Logo-19-%28002%29.jpg
NanoString to Webcast Presentation from the Jefferies Virtual Healthcare Conference


NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast a

Chemed Corporation to Present at the Jefferies 2021 Virtual Healthcare Conference
Chemed Corporation to Present at the Jefferies 2021 Virtual Healthcare Conference


Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the Jefferies 2021 Virtual Healthcare Conference on Wednesday, June 2, 2021, at approximately 11:30 a.m. (ET).

Acadia Healthcare to Participate in the Jefferies Virtual Healthcare Conference: https://mms.businesswire.com/media/20200504005676/en/583255/5/ACHC.jpg
Acadia Healthcare to Participate in the Jefferies Virtual Healthcare Conference


Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that the Company will participate in the Jefferies Virtual Healthcare Conference, which takes place June 1 – June 4, 2021. There will

Agilent Reports Second-Quarter Fiscal Year 2021 Financial Results:
Agilent Reports Second-Quarter Fiscal Year 2021 Financial Results


Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.525 billion for the second quarter ended April 30, 2021, an increase of 23% compared to the second quarter of 2020 and up 19% on a

Waters Introduces the SARS-CoV-2 LC-MS Kit (RUO) to Advance Clinical Research of Infectious Diseases
Waters Introduces the SARS-CoV-2 LC-MS Kit (RUO) to Advance Clinical Research of Infectious Diseases


Waters Corporation (NYSE:WAT) today introduced a new RUO LC-MS test method to advance critical infectious disease research. Waters™ SARS-CoV-2 LC-MS Kit (RUO) uses an orthogonal analytical method